| Document |
Document Title |
|
WO/2023/085046A1 |
The present disclosure provides an organic compound characterized by being represented by general formula [1].
|
|
WO/2023/085670A1 |
The present invention relates to a novel organic light-emitting material and an organic light-emitting device comprising same.
|
|
WO/2023/085135A1 |
At least one of the purposes of the present invention is to provide a novel compound.　The present invention provides a compound represented by chemical formula (i). (In the formula, the bond indicated by parallel broken line and solid ...
|
|
WO/2023/083828A1 |
The present invention relates to a method for preparing a cyclic anhydride such as succinic anhydride and methylsuccinic anhydride from an unsaturated carboxylic acid such as acrylic acid or crotonic acid. The invention also relates to t...
|
|
WO/2023/080106A1 |
The present invention provides a method for producing an amine containing an aromatic ring with a high yield, the method generating fewer by-products. The present invention provides a method for producing an amine containing an aromatic ...
|
|
WO/2023/078824A1 |
The present invention relates to compounds of the spiro-(indane- fluorene) type of formula (I), in particular those bearing a primary amino group and the corresponding diarylamino compounds. The invention further relates to methods for p...
|
|
WO/2023/077822A1 |
Disclosed in the present invention is a method for preparing 2,5-bishydroxymethylfuran by using 5-chloromethylfurfural, wherein 2,5-bishydroxymethylfuran can be obtained by subjecting 5-chloromethylfurfural to a one-step reaction under t...
|
|
WO/2023/078361A1 |
The present invention discloses a method for preparing 5-hydroxymethylfurfural. The method comprises: mixing materials containing a salt solution, a saccharide compound and a catalyst, and subjecting same to a reaction I so as to obtain ...
|
|
WO/2023/080187A1 |
This organic EL element (1) has a first hole transport zone (6) including a first positive electrode-side organic layer (61) and a second positive electrode-side organic layer (62). At least one of the first positive electrode-side organ...
|
|
WO/2023/080243A1 |
One purpose of the present invention is to provide a novel thioester derivative and a method for producing the same, a novel ketone derivative and a method for producing the same, a novel method for producing a C-arylhydroxyglucoside der...
|
|
WO/2023/080071A1 |
The present invention provides a method for producing 4-hydroxybutyl aldehyde, the method comprising a step in which an allyl alcohol is subjected to a hydroformylation reaction together with a carbon monoxide gas and a hydrogen gas in t...
|
|
WO/2023/078722A1 |
The present invention relates to new specific butyrate compounds to a new and improved synthesis of specific butyrates as well their use. Butyrate compounds are very useful compounds, either as such or as intermediates in organic synthesis.
|
|
WO/2023/072977A1 |
The present invention relates to a compound of formula (I), to its use in electronic devices, to methods for producing said compound, and to electronic devices containing the compound.
|
|
WO/2023/071938A1 |
The present invention relates to a method for producing succinic anhydride by means of maleic anhydride hydrogenation, comprising (1) a maleic anhydride solution and a hydrogen raw material respectively enter a first-stage hydrogenation ...
|
|
WO/2023/072975A1 |
The present invention relates to a compound of formula (I), to its use in electronic devices, to methods for producing said compound, and to electronic devices containing the compound.
|
|
WO/2023/076626A1 |
The disclosure relates to compounds of Formula (I), which are RXFP1 receptor agonists, compositions containing them, and methods of using them, for example, in the treatment of heart failure, fibrotic diseases, and related diseases such ...
|
|
WO/2023/072053A1 |
Disclosed is a method for continuously producing 5-hydroxymethylfurfural and 2,5-furandicarboxylic acid, comprising: (1) in a double-liquid phase reaction medium containing a polar organic solvent and a halogenated quaternary ammonium sa...
|
|
WO/2023/075157A1 |
The present invention relates to a compound for an organic electronic element, an organic electronic element using same, and an electronic device comprising the organic electronic element. According to the present invention, an organic e...
|
|
WO/2023/072992A1 |
The invention relates to a Mannich base of formula (I) and to the use thereof as a component of a hardener for epoxy resins. The Mannich base of formula (I) has a high Renewable Carbon Index. It makes it possible to produce high-quality ...
|
|
WO/2023/072976A1 |
The present invention relates to a compound of formula (I), to its use in electronic devices, to methods for producing said compound, and to electronic devices containing the compound.
|
|
WO/2023/072047A1 |
A method for preparing succinic anhydride by means of the hydrogenation of maleic anhydride. The method comprises: 1) mixing a maleic anhydride solution with hydrogen to obtain a first liquid phase feed; 2) enabling the first liquid phas...
|
|
WO/2023/075134A1 |
The present specification relates to an amine compound and an organic light-emitting device comprising same.
|
|
WO/2023/076494A1 |
Methods and agricultural formulations for the cultivation of plants such as broad acre crops, fruits and vegetables, perennial tree crops, and ornamentals are described. The methods include contacting the plant with a furanone compound a...
|
|
WO/2023/075158A1 |
The present invention relates to a compound for an organic electric element, an organic electric element using same, and an electronic device comprising the organic electric element. According to the present invention, an organic electri...
|
|
WO/2023/075288A1 |
According to the present invention, by forming normal pressure conditions in a reaction system through application of a reflux system to an aqueous phase in the presence of sulfuric acid and an inorganic salt in the dehydration reaction ...
|
|
WO/2023/066577A1 |
Process for the preparation of a furfural derivative having the chemical formula (1) wherein R represents hydrogen, an alkyl group or an acyl group, which process comprises (i) reacting a fructose- and/or glucose-containing starting mate...
|
|
WO/2023/068085A1 |
Provided are: a liquid crystal alignment agent which can obtain a liquid crystal alignment film having a high film strength, a suppressed AC afterimage, and a high voltage retention rate even after being exposed for a long period of time...
|
|
WO/2023/065996A1 |
The present invention relates to an anthracene derivative, an organic electroluminescent material, a light-emitting device, and a consumer product. The anthracene derivative of the present invention is a novel organic electroluminescent ...
|
|
WO/2023/062922A1 |
The present invention is a polyurethane, the polyurethane being characterized by containing a phenolic hydroxyl group represented by general formula (1A). Provided thereby are an electroconductive paste composition for forming a stretcha...
|
|
WO/2023/064220A1 |
The present invention relates to a novel furan compound, 2,2,6,6,7,8,8-heptamethyl-3,3a,4,5,5a,6,7,8-octahydro-2H-ind
eno[4,5-b]furan, and its use as a fragrance material.
|
|
WO/2023/061466A1 |
Disclosed is a preparation method for an eribulin derivative. Specifically, disclosed is a preparation method for a compound as represented by formula (I). The preparation method is high in terms of yield, mild in terms of reaction condi...
|
|
WO/2023/061999A1 |
The present invention discloses a distinct mode of action of a nickel catalyst to forge C-0 bonds to unlock the mild utilization of N2O as O-atom transfer reagent in the synthesis of complex phenols from the corresponding aryl halides.
|
|
WO/2023/059121A1 |
The present invention provides a benzofuranyl hydroxyphenyl methanone derivative compound having a specific chemical structure, a HSP47-inhibitory pharmaceutical compound comprising a pharmaceutically acceptable salt thereof, and a prepa...
|
|
WO/2023/058975A1 |
The present invention provides a pharmaceutical composition for inhibiting HSP47, the composition including a benzofuranyl hydroxyphenyl methanone derivative compound having a specific chemical structure, or a pharmaceutically acceptable...
|
|
WO/2023/059224A1 |
The invention relates to new biologically active derivatives of substituted 2,3-dihydrofuran-3-ones, which can be used as antiviral agents with a broad spectrum of antiviral activity. The compound represented by Formula (I) is described:...
|
|
WO/2023/059086A1 |
Disclosed are: a metal phosphide-based catalyst having a yolk-shell structure; and a method for converting, through hydrogenation, an organic acid, especially, an organic acid, such as levulinic acid, derived from biomass, or a derivativ...
|
|
WO/2023/052616A1 |
The invention relates to sugar amides and mixtures thereof as well as their use incosmetic or household applications and oil or mining applications.
|
|
WO/2023/054678A1 |
This organic EL element (1) comprises a light-emitting region (5) disposed between a negative electrode (4) and a positive electrode (3), a first positive-electrode-side organic layer (61), and a second positive-electrode-side organic la...
|
|
WO/2023/055999A1 |
Peptoids, compositions thereof, and methods of using the peptoids. The peptoid may be an antimicrobial peptoid. In some embodiments, the peptoid may be used to treat or prevent a fungal infection, a biofilm produced from a fungal infecti...
|
|
WO/2023/055940A1 |
The present disclosure provides compounds that modulate expressed in metabolic and inflammatory disorders targets, including peroxisome proliferator activated receptors (PPARs), phosphoenolpyruvate carboxykinase (PEPCK), poly(ADP-ribose)...
|
|
WO/2023/054429A1 |
Provided is a new method for producing an alkylfurancarboxylic acid ester, the method comprising conducting an oxidation/reduction reaction between an alkylfuranaldehyde and a compound represented by A-OH (wherein A is a C1-C10 organic g...
|
|
WO/2023/051133A1 |
The present invention relates to a spiro compound and the use thereof. The spiro compound has the structure as shown in formula (1). The material provided in the present invention has the advantages of a high optical and electrical stabi...
|
|
WO/2023/053977A1 |
The present invention provides a method for producing a salt (P) of an organic cation and an organic anion, the method comprising: (1) a step for obtaining a product which contains the salt (P) by subjecting a salt (I) of the organic cat...
|
|
WO/2023/054626A1 |
Provided is a cyclopropanamide derivative. A compound represented by formula (1) [wherein: n represents an integer of 0, 1, 2 or 3; ring A represents (1) 4-pyridyl which may be substituted with 1 to 4 substituents, or (2) phenyl which is...
|
|
WO/2023/051657A1 |
Provided are a compound as represented by formula I, and a racemate, an enantiomer, a diastereomer and a pharmaceutically acceptable salt thereof, and the use thereof in the prevention or treatment of related diseases caused by coronavir...
|
|
WO/2023/048228A1 |
Provided is a compound represented by general formula (1). In general formula (1), P1 represents a polymer structure comprising a sub-structure represented by general formula (2). In general formula (2), n is 1 or greater; when n1 is 1, ...
|
|
WO/2023/048574A1 |
The invention is directed to the preparation of furan-based surfactant or a salt thereof according to any of formula (IVa)-(IVf), wherein R3 is H, OR4 or R4; R2 is H or an aliphatic chain, R4, R5 and R6 independently are an aliphatic cha...
|
|
WO/2023/045729A1 |
The present application relates to a nitrogen-containing compound, an electronic component comprising same, and an electronic apparatus. The nitrogen-containing compound of the present application comprises a fluorenyl group, and benzocy...
|
|
WO/2023/041006A1 |
Provided is an anti-HER3 antibody drug conjugate, specifically comprising an antibody moiety, an intermediate linker moiety, and a cytotoxic drug moiety which are linked together. The provided antibody drug conjugate achieves excellent a...
|
|
WO/2023/043803A1 |
Disclosed herein are FABP4 and FABP5 inhibitor compounds and their use in pharmaceutical compositions for treating diseases relating to fatty acid metabolism, including cancer. Also disclosed herein are methods for preparing the disclose...
|
